May 28
|
Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference
|
Apr 17
|
Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
|
Apr 14
|
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?
|
Apr 14
|
High Growth Tech Stocks In US With Potential For Expansion
|
Apr 11
|
How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs
|
Apr 10
|
Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?
|
Apr 10
|
Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy
|
Apr 8
|
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?
|
Mar 14
|
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?
|
Mar 11
|
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
|
Feb 27
|
Q4 2024 Vir Biotechnology Inc Earnings Call
|
Feb 25
|
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
|
Feb 24
|
Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now
|
Feb 18
|
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
|
Feb 14
|
Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
|
Feb 14
|
Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
|
Feb 14
|
Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
Feb 14
|
Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call
|
Feb 13
|
Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say
|
Feb 13
|
Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates
|